Latest AI and machine learning research in dementia for healthcare professionals.
The early diagnosis of Alzheimer's Disease (AD) through non invasive methods remains a significant healthcare challenge. We present NeuroXVocal, a novel dual-component system that not only classifies but also explains potential AD cases through speech analysis. The classification component (Neuro) processes three distinct data streams: acoustic features capturing speech patterns and voice charac...
In the analysis of remote healthcare monitoring data, time series representation learning offers substantial value in uncovering deeper patterns of patient behavior, especially given the fine temporal granularity of the data. In this study, we focus on a dataset of home activity records from people living with Dementia. We propose a two-stage self-supervised learning approach. The first stage in...
Identifying cognitive impairment within electronic health records (EHRs) is crucial not only for timely diagnoses but also for facilitating research...
The differential diagnosis of neurodegenerative diseases, characterized by overlapping symptoms, may be challenging. Brain imaging coupled with arti...
In remote healthcare monitoring, time series representation learning reveals critical patient behavior patterns from high-frequency data. This study...
The choroid, a highly vascular layer behind the retina, is an extension of the central nervous system and has parallels with the renal cortex, with ...
Can ChatGPT diagnose Alzheimer's Disease (AD)? AD is a devastating neurodegenerative condition that affects approximately 1 in 9 individuals aged 65...
Alzheimer's disease is an untreatable, progressive brain disorder that slowly robs people of their memory, thinking abilities, and ultimately their ...
Electrocardiogram (ECG) analysis has emerged as a promising tool for identifying physiological changes associated with neuropsychiatric conditions. ...
Alzheimer's Disease (AD) is an irreversible neurodegenerative disease affecting 50 million people worldwide. Low-cost, accurate identification of ke...
Alzheimer's Disease (AD) early detection is critical for enabling timely intervention and improving patient outcomes. This paper presents a DMV fram...
Alzheimer's Disease (AD) affects over 55 million people globally, yet the key genetic contributors remain poorly understood. Leveraging recent advan...
Alzheimer's disease is an irreversible central neurodegenerative disease, and early diagnosis of Alzheimer's disease is beneficial for its prevention ...
Dementia is a general term for a group of syndromes that affect cognitive functions such as memory, thinking, reasoning, and the ability to perform ...
Functional MRI (fMRI) and single-cell transcriptomics are pivotal in Alzheimer's disease (AD) research, each providing unique insights into neural f...
Objective: Assessing Alzheimer's disease (AD) using high-dimensional radiology images is clinically important but challenging. Although Artificial I...
STUDY OBJECTIVES: Sleep disturbances lead to negative health outcomes and caregiver burden, particularly in community settings. This study aimed to in...
BACKGROUND: Mild cognitive impairment and early-stage dementia significantly impact healthcare utilization and costs, yet more than half of affected p...
Timely and accurate assessment of cognitive impairment is a major unmet need in populations at risk. Alterations in speech and language can be early...
This study explores a novel approach to advancing dementia care by integrating socially assistive robotics, reinforcement learning (RL), large langu...